Cargando…
Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE, CONFIRM, and ENDORSE”
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842109/ https://www.ncbi.nlm.nih.gov/pubmed/35173806 http://dx.doi.org/10.1177/1756286420968357 |
_version_ | 1784650987672174592 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8842109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-88421092022-02-15 Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE, CONFIRM, and ENDORSE” Ther Adv Neurol Disord Erratum SAGE Publications 2020-10-21 /pmc/articles/PMC8842109/ /pubmed/35173806 http://dx.doi.org/10.1177/1756286420968357 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Erratum Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE, CONFIRM, and ENDORSE” |
title | Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in
Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE,
CONFIRM, and ENDORSE” |
title_full | Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in
Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE,
CONFIRM, and ENDORSE” |
title_fullStr | Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in
Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE,
CONFIRM, and ENDORSE” |
title_full_unstemmed | Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in
Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE,
CONFIRM, and ENDORSE” |
title_short | Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in
Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE,
CONFIRM, and ENDORSE” |
title_sort | corrigendum to “safety and efficacy of delayed-release dimethyl fumarate in
patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of define,
confirm, and endorse” |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842109/ https://www.ncbi.nlm.nih.gov/pubmed/35173806 http://dx.doi.org/10.1177/1756286420968357 |